Events2Join

86 FR 41383


Regulations Regarding “Intended Uses” - Federal Register

[FR Doc. 2021-15980 Filed 7-30-21; 8:45 am]. BILLING CODE 4164-01-P. Published Document: 2021-15980 (86 FR 41383). Home. Home. Sections. Money ...

86 FR 41383 - Regulations Regarding “Intended Uses” - 2021-15980

This final rule amends FDA's regulations describing the types of evidence relevant to determining whether a product is intended for use as a drug or device.

Regulations Regarding "Intended Uses" (Final Rule ... - FDA

Federal government websites often end in .gov or .mil. Before ... Federal Register: 86 FR 41383, August 2, 2021. Content current as of ...

Federal Register Document Issue for 2021-08-02

Rules. Intended Uses. FR Document: 2021-15980; Citation: 86 FR 41383. PDF: Pages 41383-41402 (20 pages); Permalink. Notices. Agency Information ...

FDA Issues Final Rule On Intended Use For Drugs Devices After A ...

... 86 FR 41383 (Aug. 2, 2021)). The rule has a complicated history and has been the subject of much controversy over the last six years. In ...

“The Long and Winding Road that Leads”… Back to Where We ...

See 86 Fed. Reg. 41383 (Aug. 2, 2021). The final rule serves as a ... The Federal Food, Drug, and Cosmetic Act of 1938 (“FDCA ...

FDA Issues Final Rule Clarifying Evidence of Off-Label Marketing

86 FR 41383 at 41388. The FDA also provides several specific examples of what this evidence may look like. In evaluating whether a stent is ...

Health Care Providers Regarding Scientific Information on ... - FDA

2021 Intended Use Final Rule, 86 FR 41383 at 41386–41397, footnote 3. 18 See January 2017 Memorandum at 3–16. 19 The extra-label use of approved ...

Federal Register/Vol. 86, No. 145/Monday, August 2, 2021/Rules ...

... FR\FM\02AUR1.SGM 02AUR1 khammond on DSKJM1Z7X2PROD with RULES. Page 2. 41383. Federal Register/Vol. 86, No. 145/Monday, August 2, 2021/Rules ...

Search Database of Rules | U.S. GAO

Non-Major Federal Rule · REGULATIONS REGARDING \"INTENDED USES\"; FDA-2015-N-2002. Identifier: 0910-AI47. Fed. Reg. Number: 86 FR 41383. Effective Date: Sep 1 ...

Five Ways FDA's New Final Rule on Intended Use Could Affect ...

41,383) amending its regulations defining intended use. The ... 86 Fed. Reg. at 41,386, 41,388 (emphasis added). 2 86 Fed. Reg. at ...

FDA's Final Rule on Intended Use: 'Getting Right Back to Where We ...

... Federal Food, Drug, and Cosmetic Act (FDCA), and FDA is not ... 1 See 86 Fed. Reg. 41,383 (Aug. 2, 2021) (2021 Final Rule). 2 See 80 ...

After a long and winding road, FDA finalizes much-debated ...

[1] 86 Fed. Reg. 41,383 at 41,390-01 (Aug. 2, 2021. Contacts. Jonathan Kahan ... Federal court limits FDA discretion in “drug” vs. “device ...

2016-12612 | CFTC

branch of the legal entity''). \35\ See Proposal, 80 FR at 41383 (explaining that the status of ... \86\ See AFR at 4-5; Better Markets at 5; IATP at 3, 5 ...

Off-Label Communications & The New Intended Use Regulations

(See 86 FR 41383) (“FDA is finalizing amendments to its intended use regulations for medical products . . . to better reflect the Agency's current practices ...

Citizen Petition – Docket Number FDA-2013-P-1297 Dear Mr ...

the Federal Food, Drug, and Cosmetic Act (FD&C Act or the Act). In ... See Regulations Regarding. “Intended Uses,” 86 FR 41383, 41386 (Aug.

FDA Issues Revised Draft Guidance on “Off-Label” Communications ...

Under the Federal Food, Drug, and Cosmetic Act (FDCA) and ... See, e.g., FDA's 2021 Intended Use Final Rule, 86 FR 41383 at 41386-41388.

Safety Bulletin " Use of non LISA Laser Fibers" LISA Laser Products ...

FDA prohibits companies from marketing medical devices for uses that the federal agency has not ... ” 86 FR 41383 at 41387 (Aug. 2, 2021). Off- ...

Analyses of Section 351 - Adulterated drugs and devices, 21 U.S.C. ...

See, e.g., FDA's 2021 Intended Use Final Rule, 86 FR 41383 at 41386-41388. ... Federal Food, Drug, and Cosmetic Act (21 U.S.C. §351(a)(2)(B)).CGMP ...

Docket No. FDA-2019-P-6100 - American Association of Tissue Banks

“Intended Uses,” 86 FR 41383, 41386 (Aug. 2, 2021) (describing types of evidence that may be relevant to determining the manufacturer's ...